2. Cell Cycle/DNA Damage
  3. DNA/RNA Synthesis
  4. Chrexanthomycin C

Chrexanthomycin C is an orally active marine natural product with remarkable bioactivities. Chrexanthomycin C has binding affinity for DNA (G4C2)4 G4 with a Kd value of 2.8 mM. Chrexanthomycin C can be used for the research of neurodegenerative disease such as amyotrophic lateral sclerosis (ALS).

For research use only. We do not sell to patients.

Chrexanthomycin C Chemical Structure

Chrexanthomycin C Chemical Structure

CAS No. : 3030587-55-1

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  
Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Chrexanthomycin C Related Antibodies

Top Publications Citing Use of Products

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Chrexanthomycin C is an orally active marine natural product with remarkable bioactivities. Chrexanthomycin C has binding affinity for DNA (G4C2)4 G4 with a Kd value of 2.8 mM. Chrexanthomycin C can be used for the research of neurodegenerative disease such as amyotrophic lateral sclerosis (ALS)[1].

IC50 & Target

Kd: 2.8 mM (DNA (G4C2)4 G4)[1]
In Vitro

Chrexanthomycin C (Compounds cC) (0.1-10 mM) binds DNA (G4C2)4 G4 with a Kd value of 2.8 mM[1].
Chrexanthomycin C has good permeability, low cytotoxicity, and nonhemolytic activity[1].
Chrexanthomycin C (1.57 μM) rescues G4C2 EHR-related pathologies in cells[1].
Chrexanthomycin C selectively binds to DNA and RNA G4C2 G4s[1].
Chrexanthomycin C (0-100 μM) dramatically reduceS G4C2 EHR-caused cell death, diminish G4C2 RNA foci in (G4C2)29-expressing Neuro2a cells, and significantly eliminate ROS in HT22 cells[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Chrexanthomycin C Related Antibodies

Cell Viability Assay[1]

Cell Line: HEK293T cells
Concentration: 0.16, 1.57 and 15.67 μM
Incubation Time: 24 h
Result: Showed no cytotoxicity up to the concentration of 10 μg/mL.
In Vivo

Chrexanthomycin C (Compounds cC) (fed; 100 μM) significantly rescues eye degeneration and improve locomotor deficits in (G4C2)29-expressing[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Drosophila[1]
Dosage: 100 μM
Administration: fed
Result: Rescued G4C2 EHR-Related Pathologies in Drosophila.
Molecular Weight

638.53

Formula

C31H26O15
CAS No.
SMILES

OC1=C2C3=C(O)C(C(O)=O)=C(CC(C)=O)C=C3CCC2=C(C4=C1C(C5=CC=CC(O[C@@H]6O[C@@H]([C@H]([C@@H]([C@H]6O)O)O)C(O)=O)=C5O4)=O)O
Structure Classification
Initial Source

Streptomyces chrestomyceticus
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Chrexanthomycin C Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Chrexanthomycin C3030587-55-1DNA/RNA SynthesisG-quadruplex (G4)C9orf72 GGGGCC (G4C2)expanded hexanucleotide repeat (EHR)amyotrophic lateral sclerosis (ALS)frontotemporal dementia (FTD)neurodegenerative diseaseInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Chrexanthomycin C
Cat. No.:
HY-N10579
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

English - EN (0 KB) Français - FR (0 KB) Deutsch - DE (0 KB) Norwegian - NO (0 KB) Español - ES (0 KB) Swedish - SV (0 KB)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.